From 2,000+ patients · Aetna Delaware is already seeing results
Aetna GLP-1 coverage in Delaware: most plans require prior authorization and a BMI of 30+. The obesity rate in Delaware is 33.5%. Weight Method offers semaglutide and tirzepatide from $199/month without insurance, with licensed providers and direct shipping.
What does this insurance cover for GLP-1 medications?
Aetna classifies its GLP-1 weight loss coverage in Delaware as Partial Coverage. In practical terms, this means patients typically need prior authorization — a process that involves submitting clinical documentation, BMI records, and proof of previous weight management attempts. For Delaware residents, approval timelines range from one to six weeks, and denial rates on initial submissions remain high. Even approved patients may face specialty-tier copays that exceed $200/month.
What are the more affordable alternatives?
Weight Method exists because insurance coverage for GLP-1 weight loss medications remains inconsistent across every carrier, including Aetna in Delaware. Whether your plan offers Partial Coverage coverage or none at all, our $154/month semaglutide and $329/month tirzepatide programs provide Delaware residents with predictable, affordable access. You keep your Aetna insurance for everything else — and get your weight loss medication through a system that actually works.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
